Specific Detection of CD56 (NCAM) Isoforms for the Identification of Aggressive Malignant Neoplasms with Progressive Development

MLA

Edgar Serfling, et al. “Specific Detection of CD56 (NCAM) Isoforms for the Identification of Aggressive Malignant Neoplasms with Progressive Development.” The American Journal of Pathology, vol. 174, Apr. 2009, pp. 1160–71. EBSCOhost, https://doi.org/10.2353/ajpath.2009.080647.

APA

Edgar Serfling, Ralf C. Bargou, Hans Konrad Müller-Hermelink, Hermann Einsele, Hans-Ulrich Völker, Stefan Gattenlöhner, Thorsten Stühmer, Ellen Leich, Benjamin Etschmann, Matthias Reinhard, Andreas Rosenwald, & Georg Ertl. (2009). Specific Detection of CD56 (NCAM) Isoforms for the Identification of Aggressive Malignant Neoplasms with Progressive Development. The American Journal of Pathology, 174, 1160–1171. https://doi.org/10.2353/ajpath.2009.080647

Chicago

Edgar Serfling, Ralf C. Bargou, Hans Konrad Müller-Hermelink, Hermann Einsele, Hans-Ulrich Völker, Stefan Gattenlöhner, Thorsten Stühmer, et al. 2009. “Specific Detection of CD56 (NCAM) Isoforms for the Identification of Aggressive Malignant Neoplasms with Progressive Development.” The American Journal of Pathology 174 (April): 1160–71. doi:10.2353/ajpath.2009.080647.